Version 5.4
Bos taurus Gene: IFNAR2
Summary
InnateDB Gene IDBG-629859.3
Last Modified 2014-10-13 [Report errors or provide feedback]
Gene Symbol IFNAR2
Gene Name interferon alpha/beta receptor 2 precursor
Synonyms IFN-R; IFN-R-2; IFNBR
Species Bos taurus
Ensembl Gene ENSBTAG00000015212
Encoded Proteins
IDBP-681278
interferon alpha/beta receptor 2 precursor
Protein Structure
Useful resources Stemformatics EHFPI ImmGen
Entrez Gene
Summary Currently no Entrez Summary Available. You might want to check the Summary Sections of the Orthologs.
Gene Information
Type Protein coding
Genomic Location Chromosome 1:1593295-1627137
Strand Reverse strand
Band
Transcripts
ENSBTAT00000020239 ENSBTAP00000020239
Interactions
Number of Interactions This gene and/or its encoded proteins are associated with 0 experimentally validated interaction(s) in this database.
Gene Ontology

Molecular Function
Accession GO Term
GO:0004905 type I interferon receptor activity
GO:0005515 protein binding
GO:0019901 protein kinase binding
GO:0019962 type I interferon binding
Biological Process
GO:0006357 regulation of transcription from RNA polymerase II promoter
GO:0008283 cell proliferation
GO:0035455 response to interferon-alpha
GO:0060337 type I interferon signaling pathway
Cellular Component
GO:0005615 extracellular space
GO:0005887 integral component of plasma membrane
Orthologs
No orthologs found for this gene
Cross-References
SwissProt
TrEMBL F1MXT2
UniProt Splice Variant
Entrez Gene 282258
UniGene Bt.5508
RefSeq NM_174553
HUGO
OMIM
CCDS
HPRD
IMGT
EMBL DAAA02000033 DAAA02000034 DAAA02000035
GenPept
RNA Seq Atlas 282258

If you use InnateDB for your research, please cite the following publication:

Breuer et al., InnateDB: systems biology of innate immunity and beyond - recent updates and continuing curation. Nucl. Acids Res. (2013) 41 (D1) 

InnateDB is being developed jointly by the Brinkman Laboratory (Simon Fraser University, British Columbia, Canada), the Hancock Laboratory (University of British Columbia, Vancouver, British Columbia) and the Lynn EMBL Australia Group (South Australian Health & Medical Research Institute and Flinders University, Adelaide, Australia).

Funding is currently provided by Allergen and EMBL Australia. Previous funding has been provided by Genome Canada, the Foundation for the National Institutes of Health through the Grand Challenges in Global Health initiative and by Teagasc. InnateDB curated interactions are licensed under the Design Science License. All other data is licensed under the terms of the originating database. Contact: innatedb-mail@sfu.ca